| __timestamp | PTC Therapeutics, Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 79838000 | 205018000 |
| Thursday, January 1, 2015 | 121816000 | 392709000 |
| Friday, January 1, 2016 | 117633000 | 299694000 |
| Sunday, January 1, 2017 | 4577000 | 397061000 |
| Monday, January 1, 2018 | 12670000 | 434100000 |
| Tuesday, January 1, 2019 | 12135000 | 782200000 |
| Wednesday, January 1, 2020 | 18942000 | 1119900000 |
| Friday, January 1, 2021 | 32328000 | 2437500000 |
| Saturday, January 1, 2022 | 44678000 | 1560400000 |
| Sunday, January 1, 2023 | 65486000 | 1815800000 |
| Monday, January 1, 2024 | 1970500000 |
Unleashing the power of data
In the ever-evolving landscape of biotechnology, understanding cost dynamics is crucial. Regeneron Pharmaceuticals, Inc. and PTC Therapeutics, Inc. offer a fascinating study in contrasts over the past decade. From 2014 to 2023, Regeneron has seen its cost of revenue skyrocket by over 780%, peaking at approximately $1.82 billion in 2023. This reflects its aggressive expansion and investment in cutting-edge therapies. Meanwhile, PTC Therapeutics, Inc. has experienced a more modest increase of around 18% in the same period, reaching about $65 million in 2023. This suggests a more cautious approach, possibly focusing on niche markets or optimizing existing operations. The data highlights the diverse strategies within the biotech sector, where companies balance innovation with financial sustainability. As the industry continues to grow, these trends offer valuable insights into the financial health and strategic priorities of leading biotech firms.
Cost Insights: Breaking Down Merck & Co., Inc. and PTC Therapeutics, Inc.'s Expenses
Cost Insights: Breaking Down Amgen Inc. and Regeneron Pharmaceuticals, Inc.'s Expenses
Cost of Revenue: Key Insights for Regeneron Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Limited
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Biogen Inc.'s Expenses
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs Geron Corporation
GSK plc vs PTC Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs PTC Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Bio-Techne Corporation vs PTC Therapeutics, Inc.
Cost of Revenue Trends: Lantheus Holdings, Inc. vs PTC Therapeutics, Inc.
Cost of Revenue Comparison: PTC Therapeutics, Inc. vs MorphoSys AG
Cost Insights: Breaking Down PTC Therapeutics, Inc. and Agios Pharmaceuticals, Inc.'s Expenses
Cost of Revenue: Key Insights for PTC Therapeutics, Inc. and Travere Therapeutics, Inc.